Trial Profile
Clinical Trials Insight: 700022740
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Apr 2007
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- Sponsors Pharmion Corporation
- 26 Apr 2007 New trial record.